We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01920737
Recruitment Status : Recruiting
First Posted : August 12, 2013
Last Update Posted : January 4, 2018
Duke University
Weill Medical College of Cornell University
Lehigh Valley Health Network
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : August 2018
  Estimated Study Completion Date : August 2018